Logo
COVID-19: Pharmidex Contingency Plan
March 19, 2020

Pharmidex are taking all the necessary steps to ensure the progression of client studies during these difficult time.

COVID-19: Pharmidex Contingency Plan


We are taking all necessary steps to ensure that studies proceed, while preserving the health and safety of staff. Summary of key steps taken at Pharmidex:


- Following the relevant guidelines issued by Public Health England.


- Limiting access to only essential people in our laboratories and cancelling/rescheduling all non-critical visitors. All visitors must confirm COVID-19 status prior to arrival.


- Cancelled all non-essential business travel.


- Closely communicating with suppliers regarding the status of their inventories and their business continuity plans and identifying alternate sources for supplies.


- Implemented strict sanitization practices to prevent cross contamination between staff, including providing our staff with resources and up-to-date information and guidance.


- To prevent the potential spread of the infection amongst employees, staff will declare any potential close contact with infected individuals and follow the relevant health guidelines.


- Our operations team will ensure adequate staffing cover so as not to compromise client studies.


We will keep you updated if the situation changes resulting in any impact on progression of your projects.


Best wishes to everyone during these tough times.

March 21, 2025
We’re pleased to announce that Janette Dalay Robertson , our Business Development Manager, and Ian Knowles , our Head of Respiratory, will be attending the 2nd SMR Molecular Glues Meeting on Friday, 21st March 2025 at GSK, Stevenage. This event is a fantastic opportunity to engage with fellow scientists, innovators, and industry leaders in the field of molecular glues. Janette and Ian are eager to connect, share insights, and explore new collaborations to advance drug discovery and development. If you’re attending, don’t hesitate to reach out – they would love to meet and discuss how Pharmidex can support your research and development goals! 🔗 More about the event: https://lnkd.in/d6yiTkUi
March 12, 2025
We’re excited to announce that Martin Barrett , our Head of Business Development, will be attending Medical Technology UK 2025 on 12-13 March at Coventry Building Society Arena! 🏥💡 Martin is looking forward to connecting with fellow industry leaders, researchers, and innovators to explore new collaborations and opportunities in advancing drug discovery and development. If you're attending, don’t miss the chance to meet him and discuss how Pharmidex can support your projects! 📅 Event: Medical Technology UK 2025 📍 Location: Coventry Building Society Arena 👥 Meet Martin: 12-13 March Let’s shape the future of medical technology and drug development together! 🔬💊
March 10, 2025
We’re excited to announce that Janette Dalay Robertson , our Business Development Manager, will be attending ELRIG Research & Innovation 2025 – Big Molecules & Big Data. 📍 Where: London, UK 🗓️ Event information ( https://lnkd.in/eRUnCsie ) Janette will be happy to connect with attendees to discuss how Pharmidex can support your drug discovery and development projects. Whether you're looking to explore partnerships or learn about our innovative solutions, Janette is eager to chat! 💬 Don’t miss this opportunity to explore exciting new business possibilities with Pharmidex . 🔎 Interested in scheduling a meeting in advance? Reach out today!
More Posts
Share by: